Trade LifeStance Health Group - LFST CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.030779% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.013666% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
| Prev. Close* | 5.21 |
| Open* | 5.2 |
| 1-Year Change* | -24.75% |
| Day's Range* | 5.2 - 5.59 |
| 52 wk Range | 4.22-11.25 |
| Average Volume (10 days) | 459.14K |
| Average Volume (3 months) | 10.56M |
| Market Cap | 2.08B |
| P/E Ratio | -100.00K |
| Shares Outstanding | 375.99M |
| Revenue | 820.18M |
| EPS | -0.79 |
| Dividend (Yield %) | N/A |
| Beta | -100.00K |
| Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 27, 2023 | 5.49 | 0.41 | 8.07% | 5.08 | 5.62 | 5.08 |
| Jan 26, 2023 | 5.21 | -0.10 | -1.88% | 5.31 | 5.31 | 5.05 |
| Jan 25, 2023 | 5.22 | 0.18 | 3.57% | 5.04 | 5.26 | 4.96 |
| Jan 24, 2023 | 5.17 | 0.19 | 3.82% | 4.98 | 5.40 | 4.98 |
| Jan 23, 2023 | 5.14 | -0.01 | -0.19% | 5.15 | 5.31 | 4.98 |
| Jan 20, 2023 | 5.18 | 0.19 | 3.81% | 4.99 | 5.33 | 4.86 |
| Jan 19, 2023 | 5.02 | -0.11 | -2.14% | 5.13 | 5.21 | 4.92 |
| Jan 18, 2023 | 5.29 | -0.02 | -0.38% | 5.31 | 5.49 | 5.11 |
| Jan 17, 2023 | 5.39 | 0.26 | 5.07% | 5.13 | 5.50 | 5.02 |
| Jan 13, 2023 | 5.29 | 0.23 | 4.55% | 5.06 | 5.40 | 5.02 |
| Jan 12, 2023 | 5.17 | 0.09 | 1.77% | 5.08 | 5.19 | 4.86 |
| Jan 11, 2023 | 5.06 | 0.13 | 2.64% | 4.93 | 5.16 | 4.76 |
| Jan 10, 2023 | 4.94 | 0.17 | 3.56% | 4.77 | 5.05 | 4.56 |
| Jan 9, 2023 | 4.93 | 0.30 | 6.48% | 4.63 | 5.01 | 4.59 |
| Jan 6, 2023 | 4.68 | 0.14 | 3.08% | 4.54 | 4.73 | 4.37 |
| Jan 5, 2023 | 4.32 | -0.14 | -3.14% | 4.46 | 4.46 | 4.21 |
| Jan 4, 2023 | 4.51 | -0.05 | -1.10% | 4.56 | 4.86 | 4.44 |
| Jan 3, 2023 | 4.60 | -0.28 | -5.74% | 4.88 | 5.06 | 4.40 |
| Dec 30, 2022 | 4.87 | 0.42 | 9.44% | 4.45 | 4.95 | 4.43 |
| Dec 29, 2022 | 4.64 | 0.43 | 10.21% | 4.21 | 4.67 | 4.19 |
LifeStance Health Group Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Total revenue | 212.518 | 377.217 | 667.511 |
| Revenue | 212.518 | 377.217 | 667.511 |
| Total Operating Expense | 199.463 | 398.965 | 972.026 |
| Selling/General/Admin. Expenses, Total | 179.633 | 311.303 | 430.54 |
| Depreciation / Amortization | 6.095 | 31.045 | 54.136 |
| Unusual Expense (Income) | 2.186 | 37.184 | 21.347 |
| Other Operating Expenses, Total | 11.549 | 19.433 | 466.003 |
| Operating Income | 13.055 | -21.748 | -304.515 |
| Interest Income (Expense), Net Non-Operating | -5.409 | -22.132 | -24.511 |
| Other, Net | 0.229 | -0.531 | -4.079 |
| Net Income Before Taxes | 7.875 | -44.411 | -333.105 |
| Net Income After Taxes | 5.669 | -38.07 | -307.197 |
| Net Income Before Extra. Items | 5.669 | -38.07 | -307.197 |
| Net Income | 5.669 | -38.07 | -307.197 |
| Total Adjustments to Net Income | -64.573 | -273.244 | -36.75 |
| Income Available to Common Excl. Extra. Items | -58.904 | -311.314 | -343.947 |
| Income Available to Common Incl. Extra. Items | -58.904 | -311.314 | -343.947 |
| Diluted Net Income | -58.904 | -311.314 | -343.947 |
| Diluted Weighted Average Shares | 373.649 | 373.649 | 327.523 |
| Diluted EPS Excluding Extraordinary Items | -0.15765 | -0.83317 | -1.05015 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |
| Diluted Normalized EPS | -0.15343 | -0.7687 | -0.97291 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Total revenue | 143.132 | 160.549 | 173.835 | 189.995 | 203.095 |
| Revenue | 143.132 | 160.549 | 173.835 | 189.995 | 203.095 |
| Total Operating Expense | 145.547 | 223.99 | 298.629 | 303.86 | 268.224 |
| Selling/General/Admin. Expenses, Total | 32.019 | 84.935 | 162.047 | 151.539 | 101.575 |
| Depreciation / Amortization | 12.228 | 12.774 | 13.777 | 15.357 | 15.684 |
| Unusual Expense (Income) | 2.166 | 16.94 | 1.022 | 1.219 | 2.072 |
| Other Operating Expenses, Total | 99.134 | 109.341 | 121.783 | 135.745 | 148.893 |
| Operating Income | -2.415 | -63.441 | -124.794 | -113.865 | -65.129 |
| Interest Income (Expense), Net Non-Operating | -8.632 | -8.774 | -3.503 | -3.602 | -3.441 |
| Other, Net | -0.396 | -1.606 | -0.906 | -1.171 | -0.434 |
| Net Income Before Taxes | -11.443 | -73.821 | -129.203 | -118.638 | -69.004 |
| Net Income After Taxes | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
| Net Income Before Extra. Items | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
| Net Income | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
| Total Adjustments to Net Income | -36.75 | 0 | 0 | 0 | 0 |
| Income Available to Common Excl. Extra. Items | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
| Income Available to Common Incl. Extra. Items | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
| Diluted Net Income | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
| Diluted Weighted Average Shares | 373.649 | 313.536 | 343.394 | 346.243 | 350.849 |
| Diluted EPS Excluding Extraordinary Items | -0.12159 | -0.22337 | -0.35077 | -0.31201 | -0.17765 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.11782 | -0.14689 | -0.34883 | -0.31418 | -0.17381 |
- Annual
- Quarterly
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Total Current Assets | 27.425 | 76.28 | 266.52 |
| Cash and Short Term Investments | 3.481 | 18.829 | 148.029 |
| Cash & Equivalents | 3.481 | 18.829 | 148.029 |
| Total Receivables, Net | 19.13 | 46.934 | 94.695 |
| Accounts Receivable - Trade, Net | 18.633 | 43.706 | 76.078 |
| Prepaid Expenses | 4.814 | 10.517 | 19.454 |
| Total Assets | 280.779 | 1569.73 | 1927.11 |
| Property/Plant/Equipment, Total - Net | 22.426 | 59.349 | 152.242 |
| Property/Plant/Equipment, Total - Gross | 26.717 | 63.781 | 171.768 |
| Accumulated Depreciation, Total | -4.291 | -4.432 | -19.526 |
| Goodwill, Net | 214.614 | 1098.66 | 1204.54 |
| Intangibles, Net | 14.951 | 332.796 | 300.355 |
| Other Long Term Assets, Total | 1.363 | 2.647 | 3.448 |
| Total Current Liabilities | 55.007 | 75.921 | 116.752 |
| Accounts Payable | 3.642 | 7.688 | 14.152 |
| Accrued Expenses | 23.545 | 46.98 | 76.055 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Other Current Liabilities, Total | 27.82 | 17.515 | 25.222 |
| Total Liabilities | 144.221 | 536.895 | 382.081 |
| Total Long Term Debt | 79.314 | 362.534 | 157.416 |
| Long Term Debt | 79.314 | 362.534 | 157.416 |
| Deferred Income Tax | 0.863 | 81.226 | 54.281 |
| Other Liabilities, Total | 9.037 | 17.214 | 53.632 |
| Total Equity | 136.558 | 1032.84 | 1545.03 |
| Preferred Stock - Non Redeemable, Net | 302.913 | 0 | 0 |
| Common Stock | 0.003 | 1044.51 | 3.743 |
| Additional Paid-In Capital | 0 | 1.452 | 1898.36 |
| Retained Earnings (Accumulated Deficit) | -166.358 | -13.125 | -357.072 |
| Total Liabilities & Shareholders’ Equity | 280.779 | 1569.73 | 1927.11 |
| Total Common Shares Outstanding | 373.649 | 373.649 | 374.255 |
| Current Port. of LT Debt/Capital Leases | 3.738 | 1.323 | |
| Other Current Assets, Total | 4.342 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 109.578 | 364.06 | 328.326 | 266.52 | 263.297 |
| Cash and Short Term Investments | 39.494 | 276.187 | 212.123 | 148.029 | 113.99 |
| Cash & Equivalents | 39.494 | 276.187 | 212.123 | 148.029 | 113.99 |
| Total Receivables, Net | 47.768 | 60.069 | 70.059 | 76.078 | 94.991 |
| Accounts Receivable - Trade, Net | 47.768 | 60.069 | 70.059 | 76.078 | 94.991 |
| Prepaid Expenses | 22.316 | 27.804 | 46.144 | 42.413 | 54.316 |
| Total Assets | 1606.28 | 1914.43 | 1914.76 | 1927.11 | 1958.39 |
| Property/Plant/Equipment, Total - Net | 70.802 | 91.799 | 115.049 | 152.242 | 170.927 |
| Property/Plant/Equipment, Total - Gross | 77.843 | 101.91 | 129.125 | 171.768 | 196.18 |
| Accumulated Depreciation, Total | -7.041 | -10.111 | -14.076 | -19.526 | -25.253 |
| Goodwill, Net | 1099.68 | 1138.73 | 1160.01 | 1204.54 | 1229.3 |
| Intangibles, Net | 323.302 | 316.534 | 307.982 | 300.355 | 291.18 |
| Other Long Term Assets, Total | 2.926 | 3.3 | 3.388 | 3.448 | 3.679 |
| Total Current Liabilities | 96.757 | 112.558 | 105.205 | 116.752 | 125.597 |
| Accounts Payable | 5.913 | 9.958 | 3.074 | 14.152 | 15.136 |
| Accrued Expenses | 71.024 | 89.163 | 85.934 | 86.512 | 95.014 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 19.82 | 11.818 | 14.874 | 14.765 | 14.124 |
| Total Liabilities | 580.524 | 369.795 | 369.887 | 382.081 | 415.868 |
| Total Long Term Debt | 387.298 | 157.067 | 157.447 | 157.416 | 177.38 |
| Long Term Debt | 387.298 | 157.067 | 157.447 | 157.416 | 177.38 |
| Deferred Income Tax | 81.226 | 81.219 | 81.226 | 54.281 | 54.281 |
| Other Liabilities, Total | 15.243 | 18.951 | 26.009 | 53.632 | 58.61 |
| Total Equity | 1025.76 | 1544.63 | 1544.87 | 1545.03 | 1542.52 |
| Common Stock | 1082.26 | 3.742 | 3.742 | 3.743 | 3.744 |
| Additional Paid-In Capital | 2.057 | 1669.48 | 1790.17 | 1898.36 | 1958.17 |
| Retained Earnings (Accumulated Deficit) | -58.557 | -128.59 | -249.042 | -357.072 | -419.4 |
| Total Liabilities & Shareholders’ Equity | 1606.28 | 1914.43 | 1914.76 | 1927.11 | 1958.39 |
| Total Common Shares Outstanding | 373.649 | 373.649 | 374.149 | 374.255 | 374.323 |
| Current Port. of LT Debt/Capital Leases | 1.619 | 1.323 | 1.323 | 1.323 | |
| Preferred Stock - Non Redeemable, Net | 0 | 0 |
- Annual
- Quarterly
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Net income/Starting Line | 5.669 | -38.07 | -307.197 |
| Cash From Operating Activities | 17.048 | -8.533 | 9.42 |
| Cash From Operating Activities | 6.095 | 31.045 | 54.136 |
| Deferred Taxes | 1.76 | -6.501 | -26.945 |
| Non-Cash Items | 0.532 | 5.746 | 287.286 |
| Cash Taxes Paid | 0.254 | 0.246 | 1.093 |
| Cash Interest Paid | 4.582 | 17.149 | 22.415 |
| Changes in Working Capital | 2.992 | -0.753 | 2.14 |
| Cash From Investing Activities | -73.375 | -861.169 | -194.076 |
| Capital Expenditures | -14.314 | -38.066 | -94.492 |
| Other Investing Cash Flow Items, Total | -59.061 | -823.103 | -99.584 |
| Cash From Financing Activities | 48.463 | 912.274 | 313.856 |
| Financing Cash Flow Items | -6.987 | 600.867 | -11.18 |
| Issuance (Retirement) of Stock, Net | 0 | 20 | 549.905 |
| Issuance (Retirement) of Debt, Net | 55.45 | 291.407 | -224.869 |
| Net Change in Cash | -7.864 | 42.572 | 129.2 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -8.682 | -78.715 | -199.167 | -307.197 | -62.328 |
| Cash From Operating Activities | 9.909 | -7.006 | -21.215 | 9.42 | 3.308 |
| Cash From Operating Activities | 12.228 | 25.002 | 38.779 | 54.136 | 15.684 |
| Deferred Taxes | 0 | 0 | 0 | -26.945 | |
| Non-Cash Items | 1.315 | 46.378 | 168.39 | 287.286 | 60.584 |
| Cash Interest Paid | 6.806 | 24.889 | 28.217 | 22.415 | 3.091 |
| Changes in Working Capital | 5.048 | 0.329 | -29.217 | 2.14 | -10.632 |
| Cash From Investing Activities | -11.835 | -70.929 | -114.514 | -194.076 | -50.855 |
| Capital Expenditures | -11.081 | -31.803 | -55.815 | -94.492 | -27.91 |
| Other Investing Cash Flow Items, Total | -0.754 | -39.126 | -58.699 | -99.584 | -22.945 |
| Cash From Financing Activities | 22.591 | 335.293 | 329.023 | 313.856 | 13.508 |
| Financing Cash Flow Items | -2.824 | -7.947 | -8.622 | -11.18 | -6.161 |
| Issuance (Retirement) of Stock, Net | 0 | 555.169 | 549.905 | 549.905 | |
| Issuance (Retirement) of Debt, Net | 25.415 | -211.929 | -212.26 | -224.869 | 19.669 |
| Net Change in Cash | 20.665 | 257.358 | 193.294 | 129.2 | -34.039 |
| Cash Taxes Paid | 0.9 | 0.908 | 1.093 | -0.06 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| TPG Capital, L.P. | Private Equity | 46.6199 | 175284635 | 0 | 2022-09-30 | LOW |
| Summit Partners, L.P. | Private Equity | 12.1639 | 45734703 | 0 | 2022-09-30 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 7.5946 | 28554650 | -2973463 | 2022-09-30 | LOW |
| Lester (Michael K.) | Individual Investor | 5.7172 | 21495968 | -328615 | 2022-06-13 | LOW |
| Silversmith Capital Partners | Private Equity | 5.1973 | 19541192 | 0 | 2021-12-31 | |
| Qureshi (Danish J.) | Individual Investor | 2.5754 | 9683096 | -85879 | 2022-06-13 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.8602 | 6994133 | 832246 | 2022-09-30 | LOW |
| Stockbridge Partners LLC | Investment Advisor/Hedge Fund | 1.8169 | 6831137 | 15000 | 2022-09-30 | LOW |
| Booth (Gwendolyn H.) | Individual Investor | 1.7375 | 6532649 | -88798 | 2022-06-13 | LOW |
| Gouk (Warren) | Individual Investor | 1.586 | 5962991 | -15106 | 2022-11-07 | LOW |
| Mullins (Kevin Michael) | Individual Investor | 1.4853 | 5584540 | -82520 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2332 | 4636558 | 937454 | 2022-09-30 | LOW |
| Principal Global Investors (Equity) | Investment Advisor | 1.0256 | 3856290 | 488665 | 2022-09-30 | LOW |
| Bessler (Robert) | Individual Investor | 0.8087 | 3040694 | 0 | 2022-04-06 | LOW |
| Fidelity Institutional Asset Management | Investment Advisor | 0.6928 | 2604875 | 1070087 | 2022-09-30 | LOW |
| Rock Springs Capital Management LP | Hedge Fund | 0.5319 | 2000000 | 0 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4645 | 1746348 | 502175 | 2022-09-30 | LOW |
| Bruff (Jesse Michael) | Individual Investor | 0.4239 | 1586606 | -230098 | 2022-04-25 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3729 | 1402221 | 256009 | 2022-09-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.3515 | 1321716 | -149365 | 2021-12-31 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
LifeStance Health Company profile
Track the Lifestance Health Group, Inc. stock price today and spot the best opportunities for profitable CFD trades.
LifeStance is a US company based in Scottsdale, Arizona that was founded in 2017. The business operates outpatient care facilities all over the United States, focusing specifically on mental health services to individuals of all ages.
LifeStance Health Group made its trading debut on 10 June 2021 in a highly anticipated initial public offering (IPO). The flotation raised $720 million with the company selling 40 million shares at $18 each. The LFST stock price trades under the NASDAQ ticker symbol LFST.
LifeStance is also backed by TPG Capital, a private equity firm with around $103 billion in assets. TPG acquired a majority interest in Lifestance Health in March 2020. The IPO valued LifeStance Health Group at over $7 billion.
Successful IPO
LifeStance Health Group IPO seems particularly well-timed, given the increasing focus on mental health during the COVID-19 global pandemic. LifeStance Health also offers digital telehealth services.
There is often plenty of initial excitement when IPOs are announced, but equally often that enthusiasm quickly wanes – some companies see their share price fall just days after going public. That doesn’t seem to be the case with LFST. The LifeStance Health Group share price closed up at $21.90 on its first day of trading – that’s an impressive increase of 21.67%. The stock price has since shown a solid base at $20, which is good news for those invested in the IPO.
While the LFST IPO was clearly successful, it’s important to note that the stock could be overvalued. If you are looking for strong profit margins, it’s worth considering that LFST reported a net loss in the first quarter of 2021.
Great growth so far
In the first three months of 2021, LifeStance Health made around $143 million in revenue, according to its filings. These also showed that the company made a net loss of $8.7 million over the same period.
While this number might seem uninspiring for a company valued in the billions, it’s also important to note that this is more revenue than LifeStance Health reported for the whole of 2018. This explosion in growth suggests that the company could have the potential to become a strong player in the mental healthcare sector.
Investment options
Follow the LFST stock chart in real-time and consider trading it with contracts for difference (CFDs). As always when investing, you should make your own analysis to see if LifeStance Health Group, Inc stock price is an attractive trading opportunity for you.
With CFDs, you can go long or short on the company’s shares and trace all the latest ups and downs of the LifeStance Health Group (LFST) share price using Capital.com’s proprietary CFD trading platform
| Industry: | Healthcare Facilities & Services (NEC) |
4800 N. Scottsdale Road
Suite 6000
SCOTTSDALE
ARIZONA 85251
US
Income Statement
- Annual
- Quarterly
News
FX Weekly Outlook: USD, GBP/USD, EUR/USD Analysis
USD, GBP/USD, EUR/USD forecasts for the week ahead.
16:33, 27 January 2023
WTI, Gold, Silver – commodities weekly forecast for the week ahead
Strength to strength in the commodity space, however, topside exhaustion begins to creep in
13:53, 27 January 2023
S&P 500, Nasdaq, DAX 40, Hang Seng technical update
Can the S&P 500 hold above its 2022 descending trend line?
12:44, 26 January 2023
Amazon Q4 earnings: online retailer to feel the pinch of higher costs and slowing consumer spending
AMZN Q4 earnings preview and technical analysis
09:59, 25 January 2023
Canadian Dollar Forecast: Bank of Canada Heading Towards a Final Rate Hike
Bank of Canada expected to hike 25bps at its upcoming meeting. Focus on whether the BoC announces a pause going forward.
15:49, 24 January 2023People also watch
Still looking for a broker you can trust?
Join the 480.000+ traders worldwide that chose to trade with Capital.com